147 related articles for article (PubMed ID: 34815686)
1. Gluten Immunogenic Peptides (GIP) Point-of-Care Urine Test in Coeliac Disease Follow-up before and during the COVID-19 Lockdown in Italy.
Ciacci C; Gagliardi M; Siniscalchi M; Ruotolo M; Santonicola A; Hajji N; Zingone F
Clin Exp Gastroenterol; 2021; 14():451-456. PubMed ID: 34815686
[TBL] [Abstract][Full Text] [Related]
2. Determination of gluten immunogenic peptides for the management of the treatment adherence of celiac disease: A systematic review.
Coto L; Mendia I; Sousa C; Bai JC; Cebolla A
World J Gastroenterol; 2021 Oct; 27(37):6306-6321. PubMed ID: 34712034
[TBL] [Abstract][Full Text] [Related]
3. Gluten immunogenic peptide excretion detects dietary transgressions in treated celiac disease patients.
Costa AF; Sugai E; Temprano MP; Niveloni SI; Vázquez H; Moreno ML; Domínguez-Flores MR; Muñoz-Suano A; Smecuol E; Stefanolo JP; González AF; Cebolla-Ramirez A; Mauriño E; Verdú EF; Bai JC
World J Gastroenterol; 2019 Mar; 25(11):1409-1420. PubMed ID: 30918433
[TBL] [Abstract][Full Text] [Related]
4. Gluten Immunogenic Peptides Are Not Correlated With Reported Adherence to Gluten-Free Diet in Children With Celiac Disease.
Guz-Mark A; Perets TT; Biran N; Jack Y; Zevit N; Silbermintz A; Matar M; Nachmias-Friedler V; Waisbourd-Zinman O; Bar-Lev MR; Huta Y; Ashorov O; Gingold-Belfer R; Shamir R
J Pediatr Gastroenterol Nutr; 2023 Aug; 77(2):244-248. PubMed ID: 37204826
[TBL] [Abstract][Full Text] [Related]
5. Real-World Gluten Exposure in Patients With Celiac Disease on Gluten-Free Diets, Determined From Gliadin Immunogenic Peptides in Urine and Fecal Samples.
Stefanolo JP; Tálamo M; Dodds S; de la Paz Temprano M; Costa AF; Moreno ML; Pinto-Sánchez MI; Smecuol E; Vázquez H; Gonzalez A; Niveloni SI; Mauriño E; Verdu EF; Bai JC
Clin Gastroenterol Hepatol; 2021 Mar; 19(3):484-491.e1. PubMed ID: 32217152
[TBL] [Abstract][Full Text] [Related]
6. Comparison of weekly gluten immunogenic peptide measurement and conventional tools to assess adherence to the gluten-free diet in celiac disease: An observational prospective study.
Stefanolo JP; Temprano MP; Smecuol E; Puebla R; Portillo JD; Niveloni S; Verdú EF; Bai JC
Am J Clin Nutr; 2023 Dec; 118(6):1106-1112. PubMed ID: 37806557
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of urinary gluten immunogenic peptides in the follow-up of patients with coeliac disease.
Garzón-Benavides M; Ruiz-Carnicer Á; Segura V; Fombuena B; García-Fernandez F; Sobrino-Rodriguez S; Gómez-Izquierdo L; Montes-Cano MA; Millan-Domínguez R; Del Carmen Rico M; González-Naranjo C; Bozada-García JM; Coronel-Rodríguez C; Espin B; Díaz J; Comino I; Argüelles-Arias F; Cebolla Á; Romero-Gómez M; Rodriguez-Herrera A; Sousa C; Pizarro-Moreno Á
Aliment Pharmacol Ther; 2023 May; 57(9):993-1003. PubMed ID: 36890679
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a Single Determination of Gluten Immunogenic Peptides in Urine from Unaware Celiac Patients to Monitor Gluten-Free Diet Adherence.
Lombardo V; Scricciolo A; Costantino A; Elli L; Legnani G; Cebolla Á; Doneda L; Mascaretti F; Vecchi M; Roncoroni L
Nutrients; 2023 Mar; 15(5):. PubMed ID: 36904257
[TBL] [Abstract][Full Text] [Related]
9. Detection of gluten immunogenic peptides in the urine of patients with coeliac disease reveals transgressions in the gluten-free diet and incomplete mucosal healing.
Moreno ML; Cebolla Á; Muñoz-Suano A; Carrillo-Carrion C; Comino I; Pizarro Á; León F; Rodríguez-Herrera A; Sousa C
Gut; 2017 Feb; 66(2):250-257. PubMed ID: 26608460
[TBL] [Abstract][Full Text] [Related]
10. Determination of Urinary Gluten Immunogenic Peptides to Assess Adherence to the Gluten-Free Diet: A Randomized, Double-Blind, Controlled Study.
Monachesi C; Verma AK; Catassi GN; Franceschini E; Gatti S; Gesuita R; Lionetti E; Catassi C
Clin Transl Gastroenterol; 2021 Oct; 12(10):e00411. PubMed ID: 34613954
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Clinical Methods With the Faecal Gluten Immunogenic Peptide to Assess Gluten Intake in Coeliac Disease.
Gerasimidis K; Zafeiropoulou K; Mackinder M; Ijaz UZ; Duncan H; Buchanan E; Cardigan T; Edwards CA; McGrogan P; Russell RK
J Pediatr Gastroenterol Nutr; 2018 Sep; 67(3):356-360. PubMed ID: 29916953
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Usefulness of an Automatable Immunoassay for Monitoring Celiac Disease by Quantification of Immunogenic Gluten Peptides in Urine.
Segura V; Ruiz-Carnicer Á; Mendía I; Garzón-Benavides M; Pizarro ÁE; Comino I; Sousa C
Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049570
[TBL] [Abstract][Full Text] [Related]
13. Nutritional and Gastroenterological Monitoring of Patients With Celiac Disease During COVID-19 Pandemic: The Emerging Role of Telemedicine and Point-of-Care Gluten Detection Tests.
Costantino A; Roncoroni L; Noviello D; Nandi N; Lombardo V; Scricciolo A; Scaramella L; Vecchi M; Elli L
Front Nutr; 2021; 8():622514. PubMed ID: 33928109
[No Abstract] [Full Text] [Related]
14. The use of urine peptidomics to define dietary gluten peptides from patients with celiac disease and the clinical relevance.
Monachesi C; Catassi G; Catassi C
Expert Rev Proteomics; 2023; 20(11):281-290. PubMed ID: 37855116
[TBL] [Abstract][Full Text] [Related]
15. Effect of
Stefanolo JP; Segura V; Grizzuti M; Heredia A; Comino I; Costa AF; Puebla R; Temprano MP; Niveloni SI; de Diego G; Oregui ME; Smecuol EG; de Marzi MC; Verdú EF; Sousa C; Bai JC
World J Gastroenterol; 2024 Mar; 30(11):1545-1555. PubMed ID: 38617446
[TBL] [Abstract][Full Text] [Related]
16. Verifying Diagnosis of Refractory Celiac Disease With Urine Gluten Immunogenic Peptides as Biomarker.
Moreno ML; Sánchez-Muñoz D; Sanders D; Rodríguez-Herrera A; Sousa C
Front Med (Lausanne); 2020; 7():601854. PubMed ID: 33537327
[TBL] [Abstract][Full Text] [Related]
17. Analysis of gluten immunogenic peptides in feces to assess adherence to the gluten-free diet in pediatric celiac patients.
Roca M; Donat E; Masip E; Crespo-Escobar P; Cañada-Martínez AJ; Polo B; Ribes-Koninckx C
Eur J Nutr; 2021 Jun; 60(4):2131-2140. PubMed ID: 33057793
[TBL] [Abstract][Full Text] [Related]
18. Dose-Escalating (50-500 mg) Gluten Administration Leads to Detectable Gluten-Immunogenic-Peptides in Urine of Patients with Coeliac Disease Which Is Unrelated to Symptoms, a Placebo Controlled Trial.
Burger JPW; van Lochem EG; Roovers EA; Drenth JPH; Wahab PJ
Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565738
[TBL] [Abstract][Full Text] [Related]
19. Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients.
Comino I; Fernández-Bañares F; Esteve M; Ortigosa L; Castillejo G; Fambuena B; Ribes-Koninckx C; Sierra C; Rodríguez-Herrera A; Salazar JC; Caunedo Á; Marugán-Miguelsanz JM; Garrote JA; Vivas S; Lo Iacono O; Nuñez A; Vaquero L; Vegas AM; Crespo L; Fernández-Salazar L; Arranz E; Jiménez-García VA; Antonio Montes-Cano M; Espín B; Galera A; Valverde J; Girón FJ; Bolonio M; Millán A; Cerezo FM; Guajardo C; Alberto JR; Rosinach M; Segura V; León F; Marinich J; Muñoz-Suano A; Romero-Gómez M; Cebolla Á; Sousa C
Am J Gastroenterol; 2016 Oct; 111(10):1456-1465. PubMed ID: 27644734
[TBL] [Abstract][Full Text] [Related]
20. Study of adherence to the gluten-free diet in coeliac patients.
Fernández Miaja M; Díaz Martín JJ; Jiménez Treviño S; Suárez González M; Bousoño García C
An Pediatr (Engl Ed); 2021 Jun; 94(6):377-384. PubMed ID: 34090634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
